beta-lactams has been researched along with Multiple Myeloma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, TR; Goydel, RS; Hymel, D; Li, X; Nanna, AR; Pedzisa, L; Rader, C; Roush, WR; Walseng, E | 1 |
| Boyer, MW; Goulston, C; Hanson, KE; Kim, JH; Tricot, G; Zangari, M | 1 |
| Dalziel, C | 1 |
3 other study(ies) available for beta-lactams and Multiple Myeloma
| Article | Year |
|---|---|
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates.
Topics: Animals; Antineoplastic Agents; beta-Lactams; Catalysis; Cell Line, Tumor; Chemistry, Pharmaceutical; Epitopes, T-Lymphocyte; Female; Humans; Hydrogen-Ion Concentration; Immunoconjugates; K562 Cells; Lymphoma, Non-Hodgkin; Lysine; Mice; Multiple Myeloma; Mutation; Neoplasm Transplantation; Pharmaceutical Preparations; Syndecan-1; Trastuzumab; Xenograft Model Antitumor Assays | 2017 |
Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Outpatients; Peripheral Blood Stem Cell Transplantation; Retrospective Studies | 2014 |
JPMorgan 24th Annual Healthcare Conference.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; beta-Lactams; Cholecalciferol; Clinical Trials as Topic; Delivery of Health Care; Drug Industry; HSP90 Heat-Shock Proteins; Humans; Multiple Myeloma; Urologic Diseases; Vitamins | 2006 |